Table 1.
Mechanism of Action | Examples |
---|---|
Blocking of PCSK9/LDLR complex formation | Peptides |
Adnectins | |
Monoclonal antibodies | |
(alirocumab, evolocumab, bocozicumab) | |
Suppression of PCSK9 expression | CRISPR/Cas9 technology |
Small molecules: | |
berberine, oleanolic acid | |
Antisense nucleotides | |
siRNA | |
Interference with PCSK9 secretion | Sortilin |
Sec24a |